Thyrocare Technologies shares rose 16.75 percent, reaching a 52-week high of Rs 759 per share on the BSE in Wednesday’s intraday session. This came after the diagnostic company’s strong fiscal year 2024–2025 April–June quarter.
The company’s net profit climbed from Rs 17.3 crore during the same time last year to Rs 23.9 crore, a 38.2 percent year-over-year (YoY) gain.
Thyrocare’s revenue from operations increased 16 percent year over year to Rs 156.9 crore from Rs 134.9 crore in Q1FY24.
Thyrocare’s earnings before interest, taxes, depreciation and amortisation (Ebitda) was Rs 42.7 crore, up 23.4% from Rs 34.6 crore in the same period last year.
As of 2:07 pm, Thyrocare Technologies shares were trading 15.89 % higher at Rs 752.10.
Disclaimer: The information provided in this article is for informational purposes only and should not be considered as financial advice. The data and figures presented are based on publicly available information and may be subject to change. Before making any investment decisions, it is recommended to conduct thorough research, consult with financial advisors, and consider your individual investment goals and risk tolerance. The author and publisher of this article do not assume any responsibility for any investment decisions made based on the information provided.